BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21506098)

  • 21. Calcitonin gene-related peptide in the joint: contributions to pain and inflammation.
    Walsh DA; Mapp PI; Kelly S
    Br J Clin Pharmacol; 2015 Nov; 80(5):965-78. PubMed ID: 25923821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis.
    Borbély É; Botz B; Bölcskei K; Kenyér T; Kereskai L; Kiss T; Szolcsányi J; Pintér E; Csepregi JZ; Mócsai A; Helyes Z
    Brain Behav Immun; 2015 Mar; 45():50-9. PubMed ID: 25524130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.
    Mulak A; Larauche M; Biraud M; Million M; Rivier J; Taché Y
    Peptides; 2015 Jan; 63():71-80. PubMed ID: 25451334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis.
    Goswami SC; Mishra SK; Maric D; Kaszas K; Gonnella GL; Clokie SJ; Kominsky HD; Gross JR; Keller JM; Mannes AJ; Hoon MA; Iadarola MJ
    J Pain; 2014 Dec; 15(12):1338-1359. PubMed ID: 25281809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory effect of somatostatin receptor activation on bee venom-evoked nociceptive behavior and pCREB expression in rats.
    Li L; Luo R; Guo Y; Yao F; Cao D; Ma S; Wang J; Wang H; Zhao Y
    Biomed Res Int; 2014; 2014():251785. PubMed ID: 24895558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of the endocrine system with inflammation: a function of energy and volume regulation.
    Straub RH
    Arthritis Res Ther; 2014 Feb; 16(1):203. PubMed ID: 24524669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.
    Shi TJ; Xiang Q; Zhang MD; Barde S; Kai-Larsen Y; Fried K; Josephson A; Glück L; Deyev SM; Zvyagin AV; Schulz S; Hökfelt T
    Mol Pain; 2014 Feb; 10():12. PubMed ID: 24521084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative study of inhibitory interneurons in laminae I-III of the mouse spinal dorsal horn.
    Polgár E; Durrieux C; Hughes DI; Todd AJ
    PLoS One; 2013; 8(10):e78309. PubMed ID: 24205193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical characterisation of lamina II inhibitory interneurons that express GFP in the PrP-GFP mouse.
    Iwagaki N; Garzillo F; Polgár E; Riddell JS; Todd AJ
    Mol Pain; 2013 Oct; 9():56. PubMed ID: 24176114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.
    Pintér E; Pozsgai G; Hajna Z; Helyes Z; Szolcsányi J
    Br J Clin Pharmacol; 2014 Jan; 77(1):5-20. PubMed ID: 23432438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current imaging strategies in rheumatoid arthritis.
    Zeman MN; Scott PJ
    Am J Nucl Med Mol Imaging; 2012; 2(2):174-220. PubMed ID: 23133812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.
    Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ
    Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
    Shimon I
    Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
    Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
    Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in rats.
    Schmid HA
    Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):193-7. PubMed ID: 25658662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
    Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K
    Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.